MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Benefits of Parkinson’s Team Training Are Maintained Long-Term

    K. Lyons, E. Pollard, D. Beran, C. Hunter(†), H. Cianci, E. Book (Kansas City, USA)

    Objective: To determine if the improvements in confidence to provide and coordinate patient care and understanding of individual and other team member roles among interprofessional…
  • 2024 International Congress

    Patient-reported changes from normal in individuals with prodromal and early-motor Parkinson’s disease: a scoping review

    J. Saade, T. Mestre, G. Stebbins, A. van Wyk (Ottawa, Canada)

    Objective: To synthesize published literature about patient-reported symptoms (PRS) or changes from normal in prodromal and early motor stages of Parkinson’s disease (PD) and develop…
  • 2024 International Congress

    Study of the functional role of circulating extracellular vesicles as mediators of inflammation in cellular models of Parkinson`s disease

    A. Yadav, E. Vacchi, S. Pinton, A. Kaelin-Lang, G. Melli (Bellinzona, Switzerland)

    Objective: To study mechanisms of cellular inflammation and neurodegeneration of EVs derived from patients with PD at different disease stages in cell-based disease models. Background:…
  • 2024 International Congress

    CSF Neurogranin Levels Are Decreased in Parkinson Disease

    H. Hwang, R. Miller, T. Cash, A. Eid, E. Herries, R. White Iii, B. Maiti, S. Schindler, J. Jackson, J. Perlmutter, M. Campbell, P. Kotzbauer (SAINT LOUIS, USA)

    Objective: To investigate CSF neurogranin differences in participants with Parkinson disease (PD) and controls and to examine its association with motor and cognitive symptoms. Background:…
  • 2024 International Congress

    A Cross-Sectional Study of Sleep Disturbances in Parkinson’s Disease Patients at a Tertiary Neurological Center in Nepal

    AYU. Chandra, AVI. Chandra (Tianjin, China)

    Objective: The objective of this cross-sectional study is to assess the prevalence and types of sleep disturbances among Parkinson's disease patients receiving care at a…
  • 2024 International Congress

    Parkinsonism in setting of hypoparathyroidism

    R. Fekete (Hawthorne, USA)

    Objective: There may be overlap between symptoms of hypoparathyroidism such as tremor and bradykinesia and Parkinsonism. Recognizing this possibility allows for appropriate clinical management. Background:…
  • 2024 International Congress

    Predicting cognitive phenotypes in de novo Parkinson’s disease: an fMRI data-driven approach.

    MI. de Bartolo, A. Ojha, G. Leodori, C. Piervincenzi, G. Vivacqua, S. Pietracupa, M. Costanzo, F. D'Antonio, S. Barbetti, R. Margiotta, G. Bruno, A. Conte, A. Berardelli, G. Fabbrini, P. Pantano, D. Belvisi (Rome, Italy)

    Objective: To verify whether connectivity changes in the dorsolateral prefrontal cortex (DLPC) and the precuneus (PCun) can predict cognitive phenotypes in de novo Parkinson’s disease…
  • 2024 International Congress

    Frontal dysfunction as a cognitive biomarker in prodromal Parkinson’s disease

    SJM. Jesús Maestre, LMD. Muñoz Delgado, ACG. Castellano Guerrero, MSE. San Eufrasio, AAG. Adarmes Gómez, DMG. Macías García, PFR. Franco Rosado, BV. Villarreal, BB. Benitez, CPC. Perez Calvo, FCG. Carrillo García, JMR. Martín Rodríguez, PMR. Mir Rivera (SEVILLA, Spain)

    Objective: To assess specific cognitive biomarkers to increase the sensibility for the diagnosis of Prodromal Parkinson’s disease (pPD) that could help to identify these patients.…
  • 2024 International Congress

    Evidence of basal ganglia involvement in mask-induced inhibition

    P. Daye, A. Sangaré, B. Gaymard, P. Pouget (Ottignies-Louvain-la-Neuve, Belgium)

    Objective: This study evaluates if basal ganglia inhibitory projections to the superior colliculus are involved in the saccadic mask inhibition phenomenon. Background: Saccadic mask inhibition is…
  • 2024 International Congress

    Determinants of nocturnal arterial hypertension in Parkinson’s disease patients in Cameroon

    D. Gams Massi, J. Ndjock, A. Magnerou, Y. Mapoure Njankouo (Douala, Cameroon)

    Objective: This study aimed to determine the frequency and factors associated to nocturnal hypertension. Background: Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor…
  • « Previous Page
  • 1
  • …
  • 165
  • 166
  • 167
  • 168
  • 169
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #28953 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley